KFI
LTRN icon

Key Financial Inc’s Lantern Pharma LTRN Stock Holding History

Key Financial Inc’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8 Hold
2
– – ﹤0.01% 1353
2026
Q1 		$3 Hold
2
– – ﹤0.01% 1393
2025
Q4 		$6 Hold
2
– – ﹤0.01% 1439
2025
Q3 		$8 Hold
2
– – ﹤0.01% 1457
2025
Q2 		$6 Buy
+2
New +$7 ﹤0.01% 1435

Other funds holding LTRN

WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
EF
Entrust Financial Wayne, Pennsylvania $154M AUM
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

Key Financial Inc's LTRN Position: Q2 2026 in Review

Key Financial Inc held its Lantern Pharma (LTRN) position steady in Q2 2026 at 2 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

Key Financial Inc first reported a position in LTRN in Q2 2025 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • Key Financial Inc held 2 shares of Lantern Pharma worth $8 as of Q2 2026.
  • Key Financial Inc left its Lantern Pharma share count unchanged in Q2 2026.
  • Lantern Pharma made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1353 holding.
  • Key Financial Inc first reported a position in Lantern Pharma in Q2 2025 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.